printable banner

U.S. Department of State - Great Seal

U.S. Department of State

Diplomacy in Action

Framework for Promoting Transatlantic Economic Integration, Annex I: Fostering Cooperation and Reducing Regulatory Barriers, B. Sectoral Cooperation--Cosmetics

Bureau of European and Eurasian Affairs
June 1, 2009


Points of Contact

European Commission:
Laurent Sellès
Telephone: +32 (2) 296-3420

U.S. Government:
EU Delegation in Washington:
U.S. Mission to the EU:
Linda Tollefson FDA (Ashley Miller, FCS)


Framework Annex I, B.3 (a).


To eliminate unnecessary regulatory divergences in key sectors.

Specific Objectives

Collaborate on cosmetics regulations, in particular with a view to reducing the need for animal tests by cooperating on alternative testing methods.


FDA, the European Commission and their testing validation associations ICCVAM and ECVAM have concluded an agreement to facilitate cooperation in validating alternative tests. The International Cooperation on Cosmetics Regulation (ICCR) has validated ten out of thirty-four alternatives to date.

In September 2008, the United States and the European Union together with Canada and Japan agreed on the cooperative Framework on Alternative Tests. The Framework provides the basis by which the responsible organizations for scientifically validating proposed new alternative tests will work together by setting priorities, sharing results and leveraging each other’s resources and expertise.

Next Steps

Clarify how the Commission and Member States intend to proceed with the final implementation of the ban against animal testing, scheduled to go into effect in 2013, and ensure trade is not disrupted, given that not all relevant alternative safety tests appear to be in place.

Revised EU Cosmetics legislation contains a recast of the Cosmetics Directive on nanomaterials. The Commission proposal was adopted on February 5, 2008, then negotiation at the Council and EP level resulted in a definition for “nanomaterial”** and an obligation to label in the list of ingredients the substance name and the term “nano” in brackets. DG ENT expects adoption in Fall 2009 with an application date 3 ½ years after adoption.

**"Nanomaterial" means an insoluble or biopersistant and intentionally manufactured material with one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm.” Note that the definition may be modified by the Commission through Comitology in view of technical and scientific progress and/or definitions agreed to at the international level.

International Cooperation on Cosmetics Regulation (ICCR) (EU, USA, Japan and Canada) working group meets July 8-9 in Ispra, Italy and will discuss these issues.

Discuss nanotechnology in cosmetics and alternatives to animal testing for cosmetic ingredients at the EC/EMEA/FDA annual bilateral meeting September 27-30, 2009.

Back to Top

Do you already have an account on one of these sites? Click the logo to sign in and create your own customized State Department page. Want to learn more? Check out our FAQ!

OpenID is a service that allows you to sign in to many different websites using a single identity. Find out more about OpenID and how to get an OpenID-enabled account.